Suggest Medication For Pancreatic Cancer
Gemcitabine is known to significantly increase the median survival rate
Detailed Answer:
Hello, Madam.
I can understand your concerns.
I really feel happy for your miraculous improvement.
Gemcitabine/GEMZAR is known to improve the median survival in patients with unresectable/ metastatic pancreatic cancer.
Recently a combination of drugs has been proposed to further increase the survival period.
In patients with metastatic disease, the combination of gemcitabine and erlotinib has led to a significantly higher median survival and 1-year survival than has the use of gemcitabine alone. This has led to US Food and Drug Administration (FDA) approval of erlotinib to be used in combination with gemcitabine in advanced, unresectable pancreatic cancer.
Hence, please check with your physician if he can prescribe this combination to you considering the risk-benefit ratio.
Continue Marinol and Creon as prescribed.
Post your further queries if any.
Thank you.